Fighting a Cancer-Linked stomach bug: new combo therapies tested
NCT ID NCT07293910
Summary
This study is testing new combinations of medicines to treat H. pylori, a common stomach bacteria linked to ulcers and stomach cancer. Researchers will compare a new acid-blocking drug (vonoprazan) to a standard one, and see if adding vitamin D or probiotics helps kill the bacteria better. The goal is to find safer, more effective treatments for this hard-to-eradicate infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tanta university hospital
RECRUITINGTanta, Egypt
Conditions
Explore the condition pages connected to this study.